期刊文献+

孟鲁司特多级质谱分析

Multi-stage Mass Spectral Analysis of Montelukast
下载PDF
导出
摘要 目的研究孟鲁司特在ESI正离子模式下的质谱行为,并对其主要碎片进行归属。方法注射泵直接进样分析孟鲁司特标准品溶液,然后对准分子离子和分子离子谱中的基峰,在离子阱内进行碰撞诱导解离。结果与结论在ESI正离子模式下,孟鲁司特主要以[M+H]+形式存在,经碰撞诱导解离,依次失去H2O、CO2和含硫的支链,得到比较稳定的碎片离子m/z 422,其在更高的能量下,发生多种重排,得到复杂的子离子质谱图。 OBJECTIVE To study the fragmentation behaviors of montelukast in positive ESI mode and assign the main ions in their mass spectra. METHODS A syringe pump was used for the direct loop injections of standard solutions and then the quasi-molecular ion of montelukast and each base-peak in a mass spectrum were selected for further multi-stage analyses. RESULTS and CONCLUTION In positive ESI mode, the [M+ H]^+ ion was the most abundant peak in full scan MS. After collision induced dissociation(CID), successive losses of H2O, CO2 and a side chain containing sulphur atom were observed and a very stable ion at m/z 422 was obtained, which underwent further fragmentation at a higher energy. At last, the complex daughter ions of m/z 422 were obtained.
出处 《齐鲁药事》 2007年第10期601-602,共2页 qilu pharmaceutical affairs
关键词 孟鲁司特 多级质谱 裂解途径 Montelukast multi-stage mass spectrometry dissociation routes
  • 相关文献

参考文献4

二级参考文献38

  • 1Milano S, Cillari E D,Agostono P, et al. Ex uiuo evidence for PGE2 and L T B4involvement in cutaneous leishmaniasis:relation with ingection status and cytokine production[J].Parasitology, 1996;112:13
  • 2Drazen JM, Austen KF, Lewis RA. Compaeative airway and vascular activities of leukotrienes C-1 and D in vito and in vitro [J].Proc Natl Acad Sei USA, 1980;77:4354
  • 3Istael E, Denarkarian R, Rosenberj M, The effets of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air[J].New Engl J Med, 1990;323:1740
  • 4Meltzer S, Hasday JD, Cohn J. Bleecker ER. Inhibition of exercise-induced bronchospasm by zyleuton: a 5-lipoxygenase inhibitor [J] . Am J Respir Crit Care Med,1996;153:931
  • 5Lee Th, Walport MJ ,Wilkinson AN , et al . Slow reacting substance of anaphylaxis antagonist FPL55712 in chronic asthma. [J] Lancet, 1981;2:304.
  • 6Britton JR, Hanley SP,Tattersfield AE. The effect of an oral leukotriene D4antagonist L-649,923 on the response to inhaled antigen in asthma[J].J Allergy Clin Immunol, 1987;79:811
  • 7Bisgaard H ,Leukotriene Modifiers in Pediatric Asthma Management[J]. Pediatrics 2001 Feb;107(2):381
  • 8Stevenson DD, Simon RA, Mathison DA, et al . Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics[J].Ann Allergy Asthma Immunol 2000 Dec;85(6 Pt 1):477
  • 9Lam S,Chan H,LeRiche JC,et al.Release of leukotrienes in patients with bronchial asthma[J].J Allergy Clin Immunol,1988,81(4):711~717.
  • 10Shindo K,Fukumura M,Miyakawa K.Plasma levels of leukotriene FA during clinical course of bronchial asthma and the effect of oral prednisolone[J].Chest,1994,105(4):1 038~1 041.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部